Staff

Administrative and support staff

foto Cobi Koelemeijer

Cobi Koelemeijer

Liza Moreira

Research staff

 

Dr. Maiwenn J. Al

Office: J5-63
Phone: +31-10-4088565
Email: al@remove-this.bmg.eur.nl

Maiwenn Al obtained her Master degree in Mathematics at Leiden University in 1991. Since 1992 she has been working at the institute for Medical Technology Assessment (iMTA) at Erasmus University Rotterdam. From 1996 to 1999 she held a Pfizer Health Economics Fellowship and in 2001 she obtained her PhD degree at the Erasmus University Rotterdam. Her research focuses on modelling studies and methods for dealing with uncertainty in economic evaluations. Together with Ben van Hout, Maiwenn developed the cost-effectiveness acceptability curve, now widely used as a method to describe uncertainty around ICERs. Her most current research focuses on methods for censored data, including applications in the area of mental health care, and budget allocation models. The latter topic involves both theoretical models and a survey into the decision makers' view on health care objectives and budget constraints.

«Top


 Photo Amir Ansaripour

Amir Ansaripour

Office: J5-17
Phone: +31-10-4088860
Email: ansaripour@remove-this.bmg.eur.nl

Amir Ansaripour (1973) is a PhD student at the institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam. He obtained his PharmD in Pharmacy sciences (Shahid Beheshti University of Medical Sciences - Tehran - Iran) in 1998. Before he joined this university (2012), he was working at Iran’s social security organisation (the biggest social insurance organisation in Iran and also the biggest health insurance company with over 32 million insureds) as the deputy of planning and strategic purchasing at the SSO’s department of health. Because of his responsibilities as an expert in the health sector he has become more familiar with "health economy" and "health technology assessment" research fields as the best solutions for providing best health care services in Iran. In the coming years, he will be doing his PhD research in the area of cost-effectiveness analyses, modelling, and reimbursement policy.

«Top


Dr. Arthur E. Attema

Office: J5-61
Phone: +31-10-4089129
Email: attema@remove-this.bmg.eur.nl

Arthur E. Attema is an economist and senior researcher at iBMG/iMTA. He is part of the group of Prof Werner Brouwer. His main research interests include utility measurement and intertemporal decision making. Arthur obtained an MSc degree in Economics at the University of Amsterdam and an MSc degree in Health Economics at Erasmus University Rotterdam. He obtained a PhD degree at the Erasmus School of Economics in Rotterdam, for his dissertation on intertemporal preferences with applications to health economics, under supervision of Prof Han Bleichrodt and Prof Peter P. Wakker. Arthur is also member of the Behavioral Economics Group.

«Top


Photo Pieter van Baal

Dr. Pieter H.M. van Baal

Office: J5-31
Phone: +31-10-4089118
Email: vanbaal@remove-this.bmg.eur.nl

Pieter van Baal has a master in Economics (1998) and holds a PhD (2004) from the Erasmus University Rotterdam on a thesis called 'Computer Simulations of Criminal Deterrence: from Public Policy to Local Interaction to Individual Behaviour'. His research focuses on measuring and forecasting population health, medical consumption due to increased life expectancy and the modeling of chronic diseases. He has extensive experience in economic evaluations of public health interventions, Markov modeling, uncertainty analyses and is the main developer of PAID (Practical Application to Include future Disease costs). Before working at iBMG/iMTA he was employed by the National Institute for Public Health and the Environment (RIVM) where he was project leader of the RIVM Chronic Disease Model.

More information about Pieter van Baal.

«Top


Drs. Pieter L.H. Bakx

Office: J5-55
Phone: +31-10-4082495
Email: bakx@remove-this.bmg.eur.nl

More information about Pieter Bakx.

«Top


Drs. Clazien A.M. Bouwmans-Frijters

Office: J5-15
Phone: +31-10-4088578
Email: bouwmans@remove-this.bmg.eur.nl

Clazien Bouwmans studied Health Policy and Management at the Erasmus University from 1994 to 1999. After her graduation, she joined iMTA as a researcher. Her interest is focused on cost-effectiveness of health care interventions. However, she participated in a great range of different research projects, like the cost-effectiveness of In Vitro Fertilization, the effectiveness of alternative medical distribution systems, the application of cost information in health care quality projects, and the critical appraisal of economic evaluations in health care (EURONHEED).

«Top


Prof.dr. Werner B.F. Brouwer

Office: J5-43
Phone: +31-10-4088862
Email: brouwer@remove-this.bmg.eur.nl

Werner Brouwer is a Professor of Health Economics at the institute of Health Policy & Management (iBMG) of the Erasmus University Rotterdam, where he currently is the head of the section Health Economics and institute for Medical Technology Assessment (HE-iMTA). He obtained an MSc in Economics (1996) and a PhD in Health Economics (1999) at the Erasmus University. His main research interests are the methodology of health economic evaluations and the link between economic evaluation and health policy. He has published extensively on topics such as discounting costs and effects, measuring and valuing informal care, measuring and valuing productivity costs, quality of life measurement, extra-welfarism and the (relative) value of health gains. Werner is an Associate Editor of Health Economics.

«Top


Photo Leander Buisman

Leander Buisman MSc

Office: J5-31
Phone: +31-10-4088730
Email: buisman@remove-this.bmg.eur.nl

More information about Leander Buisman.

«Top


Laura T. Burgers MSc

Office: J5-19
Phone: +31-10-4088948
Email: burgers@remove-this.bmg.eur.nl

«Top


 

Nasuh Buyukkaramikli

Office: J5-17
Phone: +31-10-4088538
Email: buyukkaramikli@remove-this.bmg.eur.nl

Nasuh is a researcher at iBMG/IMTA. He has a master degree in Industrial Engineering (IE) from Bilkent University, Turkey (2006) and holds a PhD from Eindhoven University of Technology, The Netherlands (2012). In his dissertation, he has analyzed the integrated capacity and resource availability management in specialized and commoditized systems’ after sales environments under several flexibility options. He has a consulting experience in Health Economics/Outcome Research and Advanced Planning/Scheduling areas. He has worked in several medium to big scale projects, was the main developer of several (early-stage) cost-effectiveness/utility/benefit analysis and budget-impact models, conducted country adaptations, participated in systematic/targeted reviews, contributed to business development activities and took part in communication development with Key Opinion Leaders (KOLs), medical experts and clients. He is currently working on an auditing protocol for early prevention of technical errors in economic evaluation spreadsheet models. His research interests are economic evaluation of medical innovations/health care programs, health technology assessment, market access strategy and management of health care delivery. The main disease/medical areas he has experience in are: multiple myeloma, Duchenne muscular dystrophy, major depressive disorder, congestive/acute decompensated heart failure and contraceptives. The main methodological areas of interest are: probabilistic decision analytic modelling, statistical modelling/analysis, value of information analysis, evidence synthesis and operations research.      

«Top


Isaac Corro Ramos PhD

Office: J5-09
Phone: +31-10-4088129
Email: corroramos@remove-this.bmg.eur.nl

Isaac Corro Ramos was born in Sevilla, Spain, on March 24th, 1977. He obtained his Master’s degree in Mathematics (option Statistics and Operations Research) from the University of Sevilla in June 2001. Between June 2001 and July 2005 Isaac had several jobs in different working areas and countries. He worked as a high-school Mathematics teacher in Sevilla (Spain), as a software programmer in Madrid (Spain) and Vienna (Austria), and as a researcher in Rome (Italy). In July 2005 he started his Ph.D. at the Department of Mathematics and Computer Science of the Eindhoven University of Technology working on the STRESS (Statistical Testing and Reliability Estimation of Software Systems) project. He defended his thesis on December 15, 2009.

Since August 2009 Isaac works as a scientific researcher at the Institute for Medical Technology Assessment (iMTA) in Rotterdam, The Netherlands. Since he enrolled iMTA he has worked in several research projects whose subjects include probabilistic modelling, cost-effectiveness analysis of health care technologies, value of information analysis and discrete event simulation.

More information about Isaac Corro Ramos.

«Top


Photo Job van Exel

Drs. N. Job A. van Exel

Office: J5-45
Phone: +31-10-4082507
Email: vanexel@remove-this.bmg.eur.nl

Job van Exel is and associate professor at the institute of Health Policy & Management (iBMG), Erasmus University Rotterdam. He obtained an MSc in Economics at Erasmus University Rotterdam in 1995. Before joining iBMG, Job worked as transport economist at the Netherlands Economic Institute (NEI) from 1995 to 2000 and as health economist at the institute for Medical Technology Assessment (iMTA) from 2000 to 2006.His main research interests include the methodology of health economics, in particular the study of health behaviour, perceptions, expectations and the valuation of health and broader effects of interventions in health care. Over the past years he has developed expertise with Q-methodology. Job is committee member of the Dutch Flemish Association for Health Economics (VGE), member of the editorial board of the association’s journal, and co-founder of the lowlands Health Economists’ Study Group (lolaHESG).

More information about Job van Exel.

«Top


Drs. Margreet G. Franken

Office: J5-05
Phone: +31-10-4081372
Email: franken@remove-this.bmg.eur.nl

Margreet Franken obtained a Bachelor degree in Nursing and a Master degree in Health Economics, Policy and Law. From 1992 until 2008 she worked as a quality care manager, clinical nurse educator, and specialised coronary and intensive care nurse in hospitals in Arnhem, Rotterdam and Christchurch (New Zealand). Since 2008, Margreet has been working as a researcher at the institute of Health Policy and Management at the Erasmus University in Rotterdam. Her research interests include outcomes research of expensive drugs and drug reimbursement. Currently, she works on the Escher project of the Dutch Top Institute Pharma (TIPharma) towards her PhD focusing on drug reimbursement systems and reimbursement criteria.

«Top


Jennifer G. Gaultney MSc

Office: J5-01
Phone: +31-10-4088688
Email: gaultney@remove-this.bmg.eur.nl

Jennifer Gaultney (1982) studied epidemiology at Emory University in Atlanta, Georgia, USA where she obtained her Master of Public Health degree in 2007. One year later she obtained a Master of Science degree in Health Economics, Policy and Law with a concentration in health economics from the Erasmus University Rotterdam in Rotterdam, Netherlands. Since this time, she has been working as a researcher at the Institute for Medical Technology Assessment at the Erasmus University of Rotterdam. Her research interests include the economic evaluation of health technology and the extent to which such analyses can be useful in early phases of technology development. She is currently working in the area of oncology, particularly multiple myeloma with a focus on targeted therapies. She also focuses on the methodology for economic evaluations in innovative diagnostics. By bringing these interests together, the focus of her PhD thesis centers on the limitations to and costs of current treatment in multiple myeloma and the potential for application of individually targeted therapy.

«Top


Drs. Lucas M.A. Goossens

Office: J5-61
Phone: +31-10-4088582
Email: goossens@remove-this.bmg.eur.nl

More information about Lucas Goossens.

«Top


Drs. Saskia de Groot

Office: J5-71
Phone: +31-10-4089189
Email: s.degroot@remove-this.bmg.eur.nl

Saskia de Groot studied Health, Policy and Management at the Erasmus University in Rotterdam. She obtained her master’s degree in Health, Economics, Policy and Law in 2009. Since August 2009 she has been working as a researcher at the institute for Medical Technology Assessment (iMTA). She is currently involved in performing outcomes research in order to assess efficacious clinical utilization of expensive intramural medicines and to determine real-world cost-effectiveness information by means of collecting data from daily clinical practice on the performance of certain drugs.

«Top


Dr. Leona Hakkaart-van Roijen

Office: J5-41
Phone: +31-10-4088567
Email: hakkaart@remove-this.bmg.eur.nl

Leona Hakkaart studied economics at the Erasmus University Rotterdam from 1984 to 1989. Between 1990 and 1994 she was employed at the Department of Public Health at the Erasmus University Rotterdam. She worked on the first general cost of illness study for the Netherlands and the methodology of measuring production losses from paid and unpaid employment. From 1995 she has been employed at the institute for Medical Technology assessment as a health economist. She has been involved in many cost-of-illness and cost-effectiveness studies for a number of diseases. Furthermore, she developed the Health and Labour Questionnaire (HLQ) a frequently applied tool for measuring production losses due to illness or its treatment in economic evaluations. In 1998 she completed here thesis entitled: 'Societal perspective on the cost of illness'. Since a few years she has specialised in the area of mental health and dermatology. In co-operation with the Trimbos institute she developed the ‘Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness' (TiC-P). From 2002 she has been a member of the management team of the institute.

«Top


Renske Hoefman MSc

Office: J5-47
Phone: +31-10-4088609
Email: hoefman@remove-this.bmg.eur.nl

Renske Hoefman has been working at the Erasmus University since 2008 and is interested in the impact of informal caregiving. She is currently working on her PhD dissertation on the inclusion of informal care in economic evaluations. She focusses on the measurement and valuation of informal care with the CarerQol instrument. Renske obtained a master’s degree in Health Economics, Policy and Law at the Erasmus University Rotterdam. After graduation she worked at the The Netherlands Institute for Social Research (SCP) where she was involved in different projects on elderly and informal care.

«Top


Drs. Kim M. Holtzer-Goor

Office: J5-03
Phone: +31-10-4088539
Email: goor@remove-this.bmg.eur.nl

Kim Holtzer-Goor studied Health Policy and Management at Erasmus University Rotterdam (1998-2002) in which she obtained an MSc. From 1999 to 2002, she had been a student research assistant at the institute for Medical Technology Assessment (iMTA). After her graduation, she joined iMTA as a researcher in 2004 after 2 years of work in the mental health sector. Her field of interest is the cost-effectiveness evaluation of health care interventions. She has been involved in several health technology assessments, for example regarding carcinoma of the glottis, screening in nursing homes for elderly with low vision, the substitution of care to glaucoma patients from ophthalmologists to optometrists, costs and quality of life for different treatments for chronic leukemia, and the use of a prognostic model to prevent under- or over-treatment in patients with head and neck cancer.

«Top


Ir. Martine Hoogendoorn-Lips

Office: J5-03
Phone: +31-10-4088871
Email: hoogendoorn@remove-this.bmg.eur.nl

More information about Martine Hoogendoorn-Lips.

«Top


Drs. T.A. Kanters

Office: J5-69
Phone: +31-10-4082917
Email: kanters@remove-this.bmg.eur.nl

Tim Kanters (1983) studied Economics at Utrecht University. In 2007 he obtained a Master’s degree in Economics & Geography at this university and in 2008 he obtained a Master’s degree in Health Economics at Erasmus University Rotterdam. Since 2008, he works as a scientific researcher at the Institute for Medical Technology Assessment. His promotion research comprises the assessment of cost-effectiveness of therapies in orphan diseases. The main focus is on the cost-effectiveness of enzyme replacement therapy in Pompe disease, a rare metabolic disease.

«Top


Drs. Caroline de Sonneville-Koedoot

Office: J5-29
Phone: +31-10-4088617
Email: desonneville@remove-this.bmg.eur.nl

Caroline Koedoot obtained a Bachelor's degree in Speech and Language Therapy in 2002 and a Master’s degree in Speech and Language Pathology in 2006. From 2002 to 2007 she gained experience as a speech and language therapist at an elderly home in Schiedam. In June 2007, after a few months of working as an assistant researcher at the department of Neurology of the Erasmus Medical Centre, she joined the iBMG where she started her PhD dissertation in cooperation with the Department of Ear, Nose and Throat of the Erasmus Medical Centre in Rotterdam. Her current research focuses on the cost-effectiveness of therapy for children who stutter. Additionally, she is involved in several projects in the field of quality of life research.

«Top


Photo Marc Koopmanschap

Dr. Marc A. Koopmanschap

Office: J5-65
Phone: +31-10-4088561
Email: koopmanschap@remove-this.bmg.eur.nl

Marc Koopmanschap (1961) is associate professor of Health Economics at the Institute of Health Policy and Management and Institute for Medical Technology Assessment (PhD thesis in 1994). His main research fields are the following: the relationship between results of economic evaluation studies and health policy, in particular drug reimbursement (Top Institute Pharma Escher project); use of HTA-studies and other considerations in international drug reimbursement policy, research on criteria (including uncertainty) on drug reimbursement in Europe (MCDA). Costs and benefits of examples of extra safety regulation of several drugs (QT studies and PSURs).

He analysed the relationship between health, ageing, medical consumption and informal care in the Netspar study "living longer in good health" and follow up projects. He is intensively involved in stated preference analysis (Discrete Choice Experiments) for several target groups, such as informal caregivers and care receivers as well as policy makers in health care who are involved in drug reimbursement and market authorization of new innovative medicines. He improved the methodology of economic evaluation of health care, regarding the measurement and valuation of productivity costs in economic evaluation of health care (friction cost method, development of PRODISQ and PCQ questionnaires) and the measurement and valuation of informal care. He performed many economic evaluation studies of health care programs (or guidelines) related to cancer (screening and therapy, breast and cervical cancer), stroke (guidelines/services), diabetes, eye care, locomotor disease such as low back pain, knee/hip-arthrosis and integrated care for fragile elderly. He also coordinates and teaches in the BMG bachelor and HEPL master program (for example the course HTA).

Marc Koopmanschap published more than 160 scientific publications. ISI web of Knowledge reports that his H-index = 35.

«Top


Photo Annemieke Leunis

Annemieke Leunis MSc

Office: J5-01
Phone: +31-10-4089763
Email: leunis@remove-this.bmg.eur.nl

Annemieke Leunis (1986) studied Health, Policy and Management at the Erasmus University in Rotterdam. She obtained her master’s degree in Health, Economics, Policy and Law in 2008 with the specialization Health Economics. After her graduation, Annemieke started working as a researcher at the institute for Medical Technology Assessment (iMTA). She is currently involved in cost-effectiveness analysis of new diagnostic technologies in an early phase of the development process. These new diagnostic technologies use genetic information to guide treatment decisions for patients with acute myeloid leukemia. In addition, she has performed some methodological research regarding the estimation of utilities for a cancer-specific questionnaire. Annemieke is also active in teaching and coordinating of the minor ‘The future of health: new medical technologies’ in the Bachelor programme.

More information about Annemieke Leunis.

«Top


Photo Naomi van der Linden

Naomi van der Linden MSc

Office: J5-51
Phone: +31-10-4088886
Email: vanderlinden@remove-this.bmg.eur.nl

Naomi van der Linden (1985) studied Organizational Anthropology (BSc. obtained in 2006, VU University Amsterdam), Health Economics, Policy and Law (MSc. obtained in 2009, Erasmus University Rotterdam) and Medicine (MSc. obtained in 2010, Erasmus University Rotterdam). During the master Health Economics, Policy and Law, Naomi specialized in Health Economics and started working at the Institute for Medical Technology Assessment. After finishing her master in Medicine, she started her PhD on outcomes research in lung cancer and head and neck cancer. Currently her focus lies with the economic evaluation of oncology drugs –amongst others targeted therapies- within these disease areas. Next to her work for iMTA, she is a project member in studies in the Medical Center Haaglanden, with a focus on Emergency Medicine and patient throughput.

«Top


Drs. Claudine A.M. de Meijer

Office: J5-27
Phone: +31-10-4088857
Email: demeijer@remove-this.bmg.eur.nl

More information about Claudine de Meijer.

«Top


Mr.dr. Marten J. Poley

Office: J5-25
Phone: +31-10-4088574
Email: poleij@remove-this.bmg.eur.nl

Born in De Meern (NL) in 1976, Marten Poley attended Gymnasium education in Utrecht from 1988 to 1994. He then studied Health Policy and Management at Erasmus University Rotterdam from which he graduated MSc in 1999. From 1996 to 1999, he was a student research assistant at institute for Medical Technology Assessment (iMTA). After his graduation, he joined iMTA as a researcher. His field of interest is the cost-effectiveness evaluation of health care interventions. He has undertaken a wide range of health technology assessments, for example regarding medication distribution systems, general practitioners' laboratory test ordering, and the combining of economic and ethical arguments in prioritizing health care interventions. From 1996 onwards, his main research area has been the cost-effectiveness of neonatal and pediatric surgery. To this end, he has been part-time employed by the Department of Pediatric Surgery at Erasmus MC Sophia Children's Hospital in Rotterdam since 2002. In 2005, he obtained his PhD degree from Erasmus University Rotterdam based on his dissertation 'Cost-effectiveness of neonatal surgery: a matter of balance'. Current research activities at the Department of Pediatric Surgery range from cost-effectiveness studies of interdisciplinary care teams, parental support programs, and patient safety initiatives, to the follow-up of adults who as newborns underwent surgery for major birth defects. Finally, Marten takes part in teaching activities within the institute of Health Policy and Management (iBMG). Next to his professional activities, Marten is reading law at Erasmus University School of Law. He expects to graduate in 2007, with a LLM thesis in the field of health care law.

«Top


Photo Wameq Azfar Raza

Wameq Azfar Raza

Office: J5-23
Phone: +31-10-4088566
Email: raza@remove-this.bmg.eur.nl

Coming from Bangladesh, Wameq A Raza (1985) joined iBMG working on the evaluation of Community Based Health Insurance in India. Before this, he served as a Senior Research Associate at the Research and Evaluation Division of BRAC, Bangladesh for three years. During this time, his main areas of research focused on extreme poverty through programme impact evaluation. He completed his Bachelors in Economics from Ithaca College, NY and worked for a government institute for a year before undertaking his Masters in Economics from the University of Sussex, Brighton, UK.

More information about Wameq Azfar Raza.

«Top


Dr. W. Ken Redekop

Office: J5-38
Phone: +31-10-4088535
Email: redekop@remove-this.bmg.eur.nl

Ken Redekop, Ph.D. is an associate professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature. Current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice. Most studies relate to diabetes, cardiovascular disease, and cancer, and most involve modelling and evidence synthesis.

«Top


Ellen M. van Rooijen MD

Office: J5-11
Phone: +31-10-4088555
Email: e.vanrooijen@remove-this.bmg.eur.nl

More information about Ellen van Rooijen.

«Top


Prof.dr. Frans F.H. Rutten

Office: J5-67
Phone: +31-10-4088552
Email: f.rutten@remove-this.bmg.eur.nl

Frans F.H. Rutten, PhD., is professor of Health Economics at the Erasmus University Rotterdam and was head of the department of Health Policy and Management in 2002-2007. In 1988 he founded the institute for Medical Technology Assessment and was managing director in 1988-2000. His research interests include the methodology and application of economic evaluation of health care programs and medicines, health policy, equity issues in health care and global health issues. He chaired the organising committee of the second iHEA World Conference on Health Economics in Rotterdam, June 1999, and served as president of the international Health Economics Association (iHEA) in 2001-2002. Furthermore he was chairman of the organising committee of the European ISPOR conference in Rotterdam in November 2002. He ranked 5th in the top 40 of best publishing economists in the Netherlands in 2008 and he ranked 6th in the top 30 of best cited economists in the Netherlands in 2009.

«Top


Prof.dr. Maureen P.M.H. Rutten-van Mölken

Office: J5-66
Phone: +31-10-4088559
Email: m.rutten@remove-this.bmg.eur.nl

Extensive Curriculum Vitae

List of publications

Maureen Rutten-van Mölken is professor of economic evaluations of innovative health care for chronic diseases at the Institute for Medical Technology Assessment/Institute of Health Care Policy and Management (iMTA/iBMG) of the Erasmus University/Erasmus Medical Centre in Rotterdam. She is also vice-director of iMTA. She joined iMTA as a senior researcher in 1996. Before, she was an assistant professor in Health Economics and Medical Technology Assessment at the Department of Health Economics of the University of Maastricht. She was trained as a health scientist and had additional training in health economics and epidemiology. She obtained a MSc in health care policy and management at Maastricht University (1988), and a PhD in health economics, also at Maastricht University (1994).

Maureen's expertise includes economic evaluations alongside clinical trials as well as probabilistic decision analytic modeling, primarily in the area of respiratory diseases, smoking, rheumatology and several other chronic diseases. She has a special interest in cost-effectiveness and financing of integrated care programs. She has over 20 years of experience in health economics and outcomes research and has been project leader of many applied economic evaluations and HTA-methodology studies leading to high level publications. She is a member of the committee “Implementation” of the Netherlands Organization for Health Research and Development (ZonMW), and was a member of the scientific advisory board of the Dutch Asthma Foundation until recently.

More information about Maureen Rutten-van Mölken.

«Top


Drs. Saskia J. Schawo

Office: J5-59
Phone: +31-10-4082581
Email: schawo@remove-this.bmg.eur.nl

Saskia Schawo works as a researcher and phd candidate at the institute for Medical Technology Assessment since 2008. She holds a master’s degree in economics and has previously worked as a risk controller at an international insurance company.
Saskia is particularly interested in the economic evaluation of mental health care interventions. Her present research is focused on the cost-effectiveness of interventions for criminal youths and their families. She employs health economic methodology such as Markov modeling and discrete choice techniques to determine whether these methods can be successfully applied to the field of crime prevention and treatment. Besides her involvement in the evaluation of family therapy for criminal youths she has also been involved in an evaluation of life-style interventions for patients with obesity and high weight, an economic evaluation of medication for children suffering from ADHD and projects evaluating national guidelines for mental illnesses with respect to cost-effectiveness considerations.

«Top


Prof.dr. Hans L. Severens

Office: J5-39
Phone: +31-10-4088583
Email: severens@remove-this.bmg.eur.nl

Since 2009 Hans Severens is professor of Evaluation in Health Care at the iMTA. He holds a MSc Policy and Management in Health Sciences from the Maastricht University, and a PhD from the Radboud University Nijmegen, the Netherlands. From 2001 until 2009 he was appointed as professor of Medical Technology Assessment at Maastricht University and co-head of the department of Clinical Epidemiology and Medical Technology Assessment of the University Hospital Maastricht. Hans’ work is focused on economic evaluations of health care technologies, either as part of clinical trials or independent modelling studies and working on the research methods within this field. Since 2008 Hans is a full member of the Dutch National Health Council (GezondheidsRaad) and for over 7 years member of the Committee ‘Farmaceutische Hulp’ (CFH) of the Health Care Insurance Board (CVZ), for drug reimbursement advice). He is former member of the Board of Directors of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and was co-editor of the scientific journal of this society, ‘Value in Health’ for 10 years.

More information about Hans Severens.

«Top


Dr. Elly A. Stolk

Office: J5-45
Phone: +31-10-4088654
Email: stolk@remove-this.bmg.eur.nl

I am a researcher at the Erasmus University Medical Center in Rotterdam, where I have an appointment at the institute for Medical Technology Assessment (iMTA) since 1997. My main interests are in the measurement of individual and social preferences for informing health care decision-making. This includes both preferences for the quality of life in different health states and preferences regarding equity in the distribution of health. I am working on a dissertation on the subject of the integration of equity concerns into the framework of economic evaluations. I currently teach undergraduate courses in quality of life research.

«Top


Dr. Siok Swan Tan

Office: J5-07
Phone: +31-10-4088623
Email: tan@remove-this.bmg.eur.nl

Siok Swan Tan is a health-economist at the iMTA. She holds degrees in Business Administration and Health Policy and Management (Erasmus Universiteit Rotterdam). Siok Swan defended her PhD dissertation entitled ‘Microcosting in economic evaluations: issues of accuracy, feasibility, consistency and generalizability’ in 2009. Current studies include methodological aspects of costing studies in economic evaluations, European projects within the framework programs of the European Commission and health-economic guideline development in low-, middle- and high income countries.

«Top


Drs. Apostolos Tsiachristas

Office: J5-09
Phone: +31-10-4088867
Email: tsiachristas@remove-this.bmg.eur.nl

Apostolos has been working since June 2009 as Junior Research Fellow at the Institute for Medical Technology Assessment (iMTA) of Erasmus University Rotterdam. The main research project he is currently involved in is related to the economic evaluation of various disease management programs in The Netherlands. Apostolos is expected to obtain a PhD based on this research in 2013. Prior to his current position, Apostolos worked as consultant at APE, a public economics consultancy located in The Hague. Apostolos’ work in APE was related to health economics as well as to disability and employment policies. Apostolos completed his degree in Healthcare Management in Greece by doing a 6 months placement at the Academic Hospital Maastricht, The Netherlands. He also obtained a MSc in Health Economics Policy and Management of the Maastricht University and holds a MSc in Financial Economics of the Erasmus University Rotterdam. His main research interests are related to economic evaluation and reimbursement of innovations in health care, decision management tools in hospitals, and consumer preferences for health services.

«Top


Prof.dr. Carin A. Uyl-de Groot

Office: J5-35
Phone: +31-10-4088571
Email: uyl@remove-this.bmg.eur.nl

Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.

«Top


Liesbet J. van de Wetering MSc

Office: J5-47
Phone: +31-10-4082981
Email: vandewetering@remove-this.bmg.eur.nl

More information about Liesbet van de Wetering.

«Top


Sofie Wouters

Office: J5-47
Phone: +31-10-4089533
Email: wouters@remove-this.bmg.eur.nl

More information about Sofie Wouters.

«Top


photo Parida Wubulihasimu

Parida Wubulihasimu

Office: J5-51
Phone: +31-10-4089542
Email: wubulihasimu@remove-this.bmg.eur.nl

Parida Wubulihasimu (1986) is a PhD student at iBMG, Erasmus University Rotterdam. She obtained her master's degree in Applied Mathematics (Delft University of Technology, Netherlands in 2010), and received her bachelor’s degree in Applied Statistics (Wuhan University of Technology, China in 2008). Her PhD project is part of a Netspar project titled “Causes and consequences of increasing of life expectancy in the Netherlands”. Her research focuses on the societal consequences of changing in health, measured by health expectancy and life expectancy; as well as the costs and benefits of these changes over Dutch population.

More information about Parida Wubulihasimu.

«Top